Works matching IS 15228517 AND DT 2017 AND VI 19 AND IP 1

Results: 20
    1

    Announcements.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 142, doi. 10.1093/neuonc/now278
    Publication type:
    Article
    2
    3
    4
    5
    6

    Targeting tyrosine receptor kinase B in gliomas.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 138, doi. 10.1093/neuonc/now199
    By:
    • Pinheiro, Kelly V.;
    • Alves, Camila;
    • Buendia, Marienela;
    • Gil, Mirela S.;
    • Thomaz, Amanda;
    • Schwartsmann, Gilberto;
    • de Farias, Caroline Brunetto;
    • Roesler, Rafael
    Publication type:
    Article
    7
    8

    Tyrosine receptor kinase B is a drug target in astrocytomas.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 22, doi. 10.1093/neuonc/now139
    By:
    • Jing Ni;
    • Shaozhen Xie;
    • Ramkissoon, Shakti H.;
    • Luu, Victor;
    • Yu Sun;
    • Bandopadhayay, Pratiti;
    • Beroukhim, Rameen;
    • Roberts, Thomas M.;
    • Stiles, Charles D.;
    • Segal, Rosalind A.;
    • Ligon, Keith L.;
    • Hahn, William C.;
    • Zhao, Jean J.
    Publication type:
    Article
    9
    10
    11

    Morphological and molecular features of astroblastoma, including BRAF<sup>V600E</sup> mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 31, doi. 10.1093/neuonc/now118
    By:
    • Lehman, Norman L.;
    • Hattab, Eyas M.;
    • Mobley, Bret C.;
    • Usubalieva, Aisulu;
    • Schniederjan, Matthew J.;
    • McLendon, Roger E.;
    • Paulus, Werner;
    • Rushing, Elisabeth J.;
    • Georgescu, Maria-Magdalena;
    • Couce, Marta;
    • Dulai, Mohanpal S.;
    • Cohen, Mark L.;
    • Pierson, Christopher R.;
    • Raisanen, Jack M.;
    • Martin, Sarah E.;
    • Lehman, Trang D.;
    • Lipp, Eric S.;
    • Bonnin, Jose M.;
    • Al-Abbadi, Mousa A.;
    • Kenworthy, Kara
    Publication type:
    Article
    12

    Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 128, doi. 10.1093/neuonc/now135
    By:
    • Hu, Leland S.;
    • Shuluo Ning;
    • Eschbacher, Jennifer M.;
    • Baxter, Leslie C.;
    • Gaw, Nathan;
    • Ranjbar, Sara;
    • Plasencia, Jonathan;
    • Dueck, Amylou C.;
    • Sen Peng;
    • Smith, Kris A.;
    • Nakaji, Peter;
    • Karis, John P.;
    • Quarles, C. Chad;
    • Wu, Teresa;
    • Loftus, Joseph C.;
    • Jenkins, Robert B.;
    • Sicotte, Hugues;
    • Kollmeyer, Thomas M.;
    • O'Neill, Brian P.;
    • Elmquist, William
    Publication type:
    Article
    13

    Long-term survival in AIDS-related primary central nervous system lymphoma.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 99, doi. 10.1093/neuonc/now155
    By:
    • Gupta, Neel K.;
    • Nolan, Amber;
    • Omuro, Antonio;
    • Reid, Erin G.;
    • Chia-Ching Wang;
    • Mannis, Gabriel;
    • Jaglal, Michael;
    • Chavez, Julio C.;
    • Rubinstein, Paul G.;
    • Griffin, Ann;
    • Abrams, Donald I.;
    • Hwang, Jimmy;
    • Kaplan, Lawrence D.;
    • Luce, Judith A.;
    • Volberding, Paul;
    • Treseler, Patrick A.;
    • Rubenstein, James L.
    Publication type:
    Article
    14
    15

    CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 66, doi. 10.1093/neuonc/now136
    By:
    • Goffart, Nicolas;
    • Lombard, Arnaud;
    • Lallemand, François;
    • Kroonen, Jérôme;
    • Nassen, Jessica;
    • Di Valentin, Emmanuel;
    • Berendsen, Sharon;
    • Dedobbeleer, Matthias;
    • Willems, Estelle;
    • Robe, Pierre;
    • Bours, Vincent;
    • Martin, Didier;
    • Martinive, Philippe;
    • Maquet, Pierre;
    • Rogister, Bernard
    Publication type:
    Article
    16
    17

    Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single- and multicenter trials.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 89, doi. 10.1093/neuonc/now187
    By:
    • Ellingson, Benjamin M.;
    • Harris, Robert J.;
    • Woodworth, Davis C.;
    • Leu, Kevin;
    • Zaw, Okkar;
    • Mason, Warren P.;
    • Sahebjam, Solmaz;
    • Abrey, Lauren E.;
    • Aftab, Dana T.;
    • Schwab, Gisela M.;
    • Hessel, Colin;
    • Lai, Albert;
    • Nghiemphu, Phioanh L.;
    • Pope, Whitney B.;
    • Wen, Patrick Y.;
    • Cloughesy, Timothy F.
    Publication type:
    Article
    18
    19
    20

    Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 12, doi. 10.1093/neuonc/now190
    By:
    • Avila, Edward K.;
    • Chamberlain, Marc;
    • Schiff, David;
    • Reijneveld, Jaap C.;
    • Armstrong, Terri S.;
    • Ruda, Roberta;
    • Wen, Patrick Y.;
    • Weller, Michael;
    • Koekkoek, Johan A. F.;
    • Mittal, Sandeep;
    • Yoshiki Arakawa;
    • Choucair, Ali;
    • Gonzalez-Martinez, Jorge;
    • MacDonald, David R.;
    • Nishikawa, Ryo;
    • Shah, Aashit;
    • Vecht, Charles J.;
    • Warren, Paula;
    • van den Bent, Martin J.;
    • DeAngelis, Lisa M.
    Publication type:
    Article